Brooks Laboratories approves FY26 financials at 24th AGM
- Brooks Laboratories held its 24th AGM on September 3, 2026, via video conferencing
- Shareholders approved FY26 standalone and consolidated financial statements
- Jitendra Pratap Singh was reappointed as a director retiring by rotation
- Remuneration for President Strategy Atul Ranchal and President Trading Rajesh Mahajan was approved

*this image is generated using AI for illustrative purposes only.
Brooks Laboratories concluded its 24th Annual General Meeting on September 3, 2026. The meeting, held via video conferencing, saw shareholders approve the company’s standalone and consolidated financial statements for the fiscal year ended March 31, 2026.
Dr. Usha Singh, Non-Executive Independent Director, chaired the proceedings. A quorum of 319 members was present to transact business.
Key Resolutions Passed
The shareholders approved seven ordinary resolutions during the meeting. The key decisions included:
- Adoption of the annual audited standalone and consolidated financial statements for FY26.
- Reappointment of Mr. Jitendra Pratap Singh as a director, replacing those retiring by rotation.
- Ratification of cost auditor remuneration.
- Approval of related party transactions.
- Remuneration approval for Mr. Atul Ranchal, President – Strategy, and Mr. Rajesh Mahajan, President – Trading, under Section 188(1)(f) of the Companies Act, 2013.
Management Presence
The following directors and key managerial personnel attended the meeting via video conference:
- Dr. Usha Singh, Non-Executive Independent Director
- Mr. Bhushan Singh Rana, Wholetime Director
- Mr. Manav Mahajan, Non-Executive Independent Director
- Mr. Lalit Mahajan, Non-Executive Independent Director
- Mr. Jitendra Pratap Singh, Wholetime Director
- Dr. Durga Shankar Maity, Wholetime Director
- Mr. Prashant Rathi, Chief Executive Officer & Chief Financial Officer
- Ms. Krutika Rane, Company Secretary
Statutory Auditor Ms. Malavika Lokeshwar and Secretarial Auditors Mr. P.D. Sharma and Mr. G. S Sarin were also present. Mr. G. S Sarin served as the scrutinizer for the e-voting process.
Voting Process
The company provided remote e-voting facilities in compliance with SEBI Listing Regulations. The e-voting facility remained available for 15 minutes after the meeting’s conclusion. Detailed voting results are to be submitted to BSE Limited and National Stock Exchange of India Ltd within two working days.
Historical Stock Returns for Brooks Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.46% | +2.07% | +5.20% | +2.43% | -52.56% | -47.34% |
How will the approved remuneration structure for key strategy and trading executives impact Brooks Laboratories' operational costs and profit margins in FY27?
What strategic initiatives is Mr. Jitendra Pratap Singh expected to prioritize following his reappointment as a director?
How might the approved related party transactions influence the company's supply chain resilience or cost efficiency in the coming fiscal year?


































